BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10022731)

  • 21. Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis.
    Erdamar S; Yang G; Harper JW; Lu X; Kattan MW; Thompson TC; Wheeler TM
    Mod Pathol; 1999 Aug; 12(8):751-5. PubMed ID: 10463475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis of androgen-independent prostate cell line induced by inhibition of fatty acid synthesis.
    Furuya Y; Akimoto S; Yasuda K; Ito H
    Anticancer Res; 1997; 17(6D):4589-93. PubMed ID: 9494573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclin E dependent kinase activity in human breast cancer in relation to cyclin E, p27 and p21 expression and retinoblastoma protein phosphorylation.
    Lodén M; Nielsen NH; Roos G; Emdin SO; Landberg G
    Oncogene; 1999 Apr; 18(16):2557-66. PubMed ID: 10353599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [G1 block of the cell cycle during differentiation of F9 cells correlates with accumulation of inhibitors of the activity of cyclin-kinase complexes of proteins p21/Waf1 and p27/Kip].
    Malashicheva AB; Kisliakova TV; Pospelov VA
    Tsitologiia; 2002; 44(7):649-55. PubMed ID: 12455373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
    Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DCC expression is related to mucinous differentiation but not changes in expression of p21(WAF1/Cip1) and p27Kip1, apoptosis, cell proliferation and human papillomavirus infection in uterine cervical adenocarcinomas.
    Saegusa M; Okayasu I
    Br J Cancer; 1999 Apr; 80(1-2):51-8. PubMed ID: 10389977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered prostatic epithelial proliferation and apoptosis, prostatic development, and serum testosterone in mice lacking cyclin-dependent kinase inhibitors.
    Mukai M; Dong Q; Hardy MP; Kiyokawa H; Peterson RE; Cooke PS
    Biol Reprod; 2005 Nov; 73(5):951-8. PubMed ID: 16014817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of cyclin-dependent kinase inhibitors in leukemia].
    Polák J; Peková S; Schwarz J; Kozák T; Haskovec C
    Cas Lek Cesk; 2003 Jan; 142(1):25-8. PubMed ID: 12693294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma.
    Cheng JD; Werness BA; Babb JS; Meropol NJ
    Clin Cancer Res; 1999 May; 5(5):1057-62. PubMed ID: 10353738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced expression of p27/Kip1 is associated with the development of pulmonary adenocarcinoma.
    Hayashi H; Ito T; Yazawa T; Ikeda M; Inayama Y; Nakatani Y; Kameda Y; Nakamura N; Kitamura H
    J Pathol; 2000 Sep; 192(1):26-31. PubMed ID: 10951396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-6 induces G1 arrest through induction of p27(Kip1), a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells.
    Mori S; Murakami-Mori K; Bonavida B
    Biochem Biophys Res Commun; 1999 Apr; 257(2):609-14. PubMed ID: 10198259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgenic regulation of growth factor and growth factor receptor expression in the CWR22 model of prostatic adenocarcinoma.
    Myers RB; Oelschlager D; Manne U; Coan PN; Weiss H; Grizzle WE
    Int J Cancer; 1999 Jul; 82(3):424-9. PubMed ID: 10399960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of cyclin dependent kinase inhibitor p21WAF1 alone and in combination with p27KIP1 shows prognostic value in gastric carcinoma.
    Jang SJ; Ahn MJ; Paik SS; Kong G; Keum JS; Park YW; Lee JD
    J Korean Med Sci; 1998 Aug; 13(4):369-76. PubMed ID: 9741540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of cyclin-dependent kinase inhibitors p21 and p27 in pressure-overload hypertrophy.
    Li JM; Brooks G
    Am J Physiol; 1997 Sep; 273(3 Pt 2):H1358-67. PubMed ID: 9321826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of the proliferative fraction of a transplantable, hormone-dependent, human prostatic carcinoma (PC-82) by monoclonal antibody Ki-67: potential application for hormone therapy monitoring.
    Gallee MP; van Steenbrugge GJ; ten Kate FJ; Schroeder FH; van der Kwast TH
    J Natl Cancer Inst; 1987 Dec; 79(6):1333-40. PubMed ID: 3320449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of cyclin-dependent kinase inhibitors produces adipocyte hyperplasia and obesity.
    Naaz A; Holsberger DR; Iwamoto GA; Nelson A; Kiyokawa H; Cooke PS
    FASEB J; 2004 Dec; 18(15):1925-7. PubMed ID: 15469964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re: Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma.
    Rubin MA
    J Natl Cancer Inst; 1999 Jan; 91(1):91. PubMed ID: 9890179
    [No Abstract]   [Full Text] [Related]  

  • 39. Coordinate loss of growth regulatory factors following castration of rats carrying the Dunning R3327 G prostatic tumor.
    Rubenstein M; Shaw M; Targonski P; McKiel CF; Dubin A; Guinan PD
    Clin Physiol Biochem; 1992; 9(2):47-50. PubMed ID: 1284786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independence.
    Agus DB; Cordon-Cardo C; Fox W; Drobnjak M; Koff A; Golde DW; Scher HI
    J Natl Cancer Inst; 1999 Nov; 91(21):1869-76. PubMed ID: 10547394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.